But my question is, what are you doing to make sure that we don't come to a place like this again, and to hold McKinsey accountable for failure to disclose what is an apparent conflict of interest?
Editor's note · Context
Hassan questions FDA's accountability regarding McKinsey's conflicts of interest.
Share
More from Maggie Hassan
We cannot let up now and must keep doing everything we can to keep fighting.
Your actions to provide the new weight-loss drug Retatrutide to one well-connected individual come as the Trump Administration has driven prescription drug costs for Americans through the roof.
Despite the potential effectiveness of NII in the fight against fentanyl trafficking and the Congressional mandate for its deployment, CBP has been slow to deploy NII technology and currently has no plans for additional equipment at…
This bipartisan bill takes a series of major steps forward to crack down on big corporate investors that buy up housing communities, build more homes that people can afford, and restore the American dream of homeownership.





